Coagulation tests measure how effectively your blood clots. They're ordered in a range of situations: before surgery, when blood-thinning medication needs monitoring, when unexplained bleeding or bruising occurs, and when certain conditions affecting clotting are suspected.
Despite appearing on lab reports frequently, these tests confuse many patients. Here's what each one measures and what an abnormal result actually indicates.
Why clotting matters
Blood clotting is a precise cascade of reactions involving clotting factors, platelets and vessel wall proteins. When you're injured, this cascade forms a clot to stop bleeding. When the cascade is too active, clots form where they shouldn't — in veins (DVT) or arteries (heart attacks, strokes). When it's too slow, bleeding persists beyond what's expected from an injury.
Coagulation tests measure where on this spectrum your blood falls.
PT — Prothrombin Time
PT measures how long it takes blood to clot via the extrinsic pathway — the route triggered by tissue damage. It specifically tests clotting factors I, II, V, VII and X.
Normal range: approximately 11–13.5 seconds (though lab reference ranges vary). A prolonged PT means clotting is slower than normal — the relevant factors are deficient or inhibited.
Common reasons for a prolonged PT: warfarin (which works by inhibiting vitamin K-dependent factors), liver disease (the liver makes most clotting factors), vitamin K deficiency, and certain clotting factor deficiencies.
INR — International Normalised Ratio
INR standardises PT results so they're comparable across different laboratories and reagents. It's calculated by comparing your PT to a normal control value.
For people not on anticoagulants, a normal INR is approximately 0.8–1.1. For people taking warfarin to prevent blood clots, the target INR is usually 2.0–3.0 (meaning blood clots two to three times more slowly than normal). For mechanical heart valves, targets are higher — 2.5–3.5.
INR monitoring is the primary tool for managing warfarin therapy. If your INR is too low, the warfarin isn't providing adequate protection. If it's too high, bleeding risk is elevated.
aPTT — Activated Partial Thromboplastin Time
aPTT measures the intrinsic pathway of clotting — a different route involving factors VIII, IX, XI and XII, among others. Normal range: approximately 25–35 seconds.
A prolonged aPTT suggests deficiency or inhibition of the intrinsic pathway factors. Common causes include heparin therapy (heparin works primarily through this pathway), haemophilia A (factor VIII deficiency) and haemophilia B (factor IX deficiency), and the presence of lupus anticoagulant.
In hospital settings, aPTT is used to monitor unfractionated heparin therapy in the same way INR is used to monitor warfarin.
Fibrinogen
Fibrinogen is the protein converted to fibrin — the mesh that holds a clot together. It's measured when there's concern about disseminated intravascular coagulation (DIC), liver disease or certain clotting disorders. Low fibrinogen impairs the final step of clot formation, even when the upstream factors are present.
What abnormal results mean in practice
A single abnormal coagulation result in a healthy person who isn't on anticoagulants usually prompts investigation for a cause — liver function tests, vitamin K levels, factor assays — rather than immediate intervention. The result is a signal that something needs explanation, not an emergency in itself.
For patients on warfarin or heparin, the interpretation is different: the abnormality is expected and intentional. What matters is whether it falls within the therapeutic target range.
Keep your coagulation results in sequence over time. The trend — and how results change in response to medication adjustments — is more meaningful than any individual reading.